Telehealth General Psychiatry Prescribing: What PMHNPs Can Do

If you’re a psychiatrist or psychiatric nurse practitioner trying to make sense of prescribing rules in 2026, you’re not alone. Between federal DEA waivers that keep getting extended, state-by-state scope-of-practice chaos, and telehealth regulations that seem to change every legislative session, it’s enough to make anyone’s head spin.

Here’s the reality: prescribing psychiatric medications—especially controlled substances—via telehealth is more accessible than ever, but the rules depend heavily on where you practice and what letters come after your name. Psychiatrists have universal authority. PMHNPs? It depends on whether you’re in Texas (restricted), New York (independent after 2 years), or somewhere in between.

This guide cuts through the noise. We’ll cover what psychiatrists and PMHNPs can actually prescribe via telehealth, how scope-of-practice laws differ across major states, what collaborative agreements really entail, and how reimbursement works for medication management. If you’re navigating multi-state licensure or trying to understand why your PMHNP colleague in California has different authority than one in Florida, you’ll find answers here.

The Current State of Telehealth Prescribing in Psychiatry

The short version: As of February 2026, psychiatrists and many PMHNPs can prescribe psychiatric medications—including Schedule II stimulants and other controlled substances—via telehealth without an initial in-person visit, thanks to federal DEA flexibilities extended through December 31, 2025.

The longer version: The Ryan Haight Act historically required an in-person exam before prescribing controlled substances. During COVID-19, the DEA waived this requirement for telemedicine. That waiver has been extended multiple times and remains in effect through the end of 2025, allowing providers to initiate treatment for ADHD, anxiety disorders requiring benzodiazepines, or opioid use disorder (buprenorphine) entirely via video visits.

What this means for your practice:

• You can start a new patient on Adderall or Ritalin via a telehealth visit (as long as you meet standard-of-care requirements)
• You can prescribe controlled substances for psychiatric conditions remotely in most states
• You cannot ignore state-specific restrictions—some states still prohibit certain uses of controlled substances via telehealth (like chronic pain management in Texas)

The catch: The DEA has proposed new permanent rules that could reinstate some in-person requirements or create a special telemedicine registration system. These rules haven’t been finalized as of early 2026, but providers should monitor DEA announcements closely. For now, the temporary flexibilities hold, and psychiatric practice continues largely unchanged from 2023-2024.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrist vs PMHNP Prescribing Authority: Understanding the Gap

The difference between what a psychiatrist can do versus what a PMHNP can do comes down to state scope-of-practice laws—and those laws are all over the map.

Psychiatrists (MD/DO): Universal Independence

Bottom line: If you’re a psychiatrist with a state medical license and DEA registration, you have full prescriptive authority everywhere. No supervision. No collaborative agreements. No caps on what you can prescribe (within your competency and specialty).

The only limitations you face are:

• Federal controlled substance rules (DEA registration required)
• State-specific telehealth prescribing restrictions (e.g., Texas won’t let you prescribe Schedule II opioids for chronic pain via telemedicine)
• Standard-of-care requirements (establish a valid patient-physician relationship, document appropriately, check prescription monitoring programs)

That’s it. A Texas psychiatrist has the same legal authority as a California psychiatrist when it comes to prescribing—state scope laws don’t restrict physicians.

PMHNPs: It Depends on Your State (and Experience)

For psychiatric nurse practitioners, your prescribing authority depends entirely on where you practice. States fall into three categories:

1. Full Practice Authority (FPA) States – You can practice independently, prescribe controlled substances under your own DEA registration, and open your own practice without physician oversight.

Examples: Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, Alaska, Hawaii, Montana, Wyoming, Idaho, Nevada, North Dakota, South Dakota, Iowa, Nebraska, Rhode Island, Connecticut, Vermont, New Hampshire, Maine, Maryland, DC, and more. As of 2025, approximately 34 states grant NPs full practice authority.

Recent additions: Massachusetts (2021), Kansas (2022), Indiana (2023), Louisiana (2024), Michigan (2025).

What this means: A PMHNP in Colorado can do everything a psychiatrist can do from a prescribing standpoint—evaluate patients, diagnose conditions, prescribe medications including Schedule II stimulants, manage treatment independently. The only difference is nursing board oversight vs medical board oversight and potentially lower reimbursement (85% of physician rates under Medicare).

2. Reduced Practice States – You have some independence but need a collaborative agreement with a physician for prescribing or certain aspects of care. Often there’s a transition period where you start with supervision and can earn independence after accumulating practice hours.

Examples: New York, Illinois, California (transitioning), and about a dozen others.

New York: PMHNPs must practice under a written collaborative agreement with a physician for their first 3,600 hours (roughly 2 years full-time). After that, they practice independently with only a loose ‘collaborative relationship’ requirement (informal consultation access). No chart reviews. No co-signatures. Effectively full independence after the transition period.

Illinois: NPs need 4,000 hours of supervised practice plus 250 hours of continuing education to apply for Full Practice Authority licensure. Until then, they must have a written collaborative agreement, and their prescriptions technically fall under the delegating physician’s authority (physician’s name appears on scripts). After meeting requirements, they get independent prescriptive authority.

California: Historically restricted, but AB 890 (passed 2020) created a pathway to independence. As of January 2023, experienced NPs (≥3 years) can become ‘103 NPs’ and practice without direct physician supervision in group settings. Starting January 2026, they can become ‘104 NPs’ and practice fully independently even in solo practice settings. New graduates still need standardized procedures and physician oversight for their first three years.

What this means: If you’re a new PMHNP in New York or Illinois, expect to work under a psychiatrist or physician collaborator initially. After a couple years and meeting requirements, you’ll have the same functional authority as an experienced NP in a full-practice state. California PMHNPs are in the middle of this transition right now—if you have the experience, you’re gaining independence; if you’re new, you’re still supervised.

3. Restricted Practice States – You need continuous physician supervision or delegation for all prescribing, regardless of experience. No pathway to independence exists.

Examples: Texas, Florida (for psychiatric NPs specifically), Pennsylvania, Alabama, Georgia, South Carolina, Tennessee, Mississippi.

Texas: All PMHNPs must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe anything. The physician must be available for consultation, and the agreement must detail what the NP can prescribe. Texas law also prohibits NPs from prescribing Schedule II controlled substances in most outpatient settings (exceptions for terminal illness or very specific ADHD protocols for children). This means Texas PMHNPs generally cannot initiate stimulants for adult ADHD patients—the collaborating physician must write those prescriptions.

Additionally, Texas caps physician supervision at 7 NPs per physician, and requires monthly face-to-face meetings for the first three years of any agreement, then quarterly thereafter.

Florida: Florida passed autonomous practice legislation in 2020 (HB 607), but it only applies to primary care NPs (family medicine, internal medicine, pediatrics). Psychiatric NPs were explicitly excluded. PMHNPs in Florida must practice under a physician’s protocol and can only prescribe controlled substances with physician delegation. However, Florida has a carve-out: PMHNPs designated as ‘psychiatric nurses’ (with 2+ years of experience under a psychiatrist) can prescribe psychotropic controlled substances for mental health treatment without the 7-day Schedule II limit that applies to other NPs. They still need a collaborating psychiatrist—but at least they can manage ADHD meds and anxiety prescriptions for longer than a week.

Pennsylvania: All NPs, regardless of experience, must maintain a collaborative agreement with a physician. The agreement must specify prescriptive authority, and the physician must review a percentage of the NP’s charts regularly. Schedule II prescriptions by NPs are limited to 30-day supplies initially, and the physician must be notified within 24 hours. There’s no independent practice pathway (though legislation has been introduced repeatedly).

What this means: If you’re a PMHNP in Texas, Florida, or Pennsylvania, you cannot practice independently. You need a physician willing to collaborate (which can be expensive—many charge $1,000-3,000/month for collaboration), and your scope will be limited by what that physician is comfortable delegating. For telehealth platforms, this often means these states require an employed or contracted psychiatrist to oversee NPs, adding operational complexity.

Why This Matters for Telehealth Practices

If you’re considering joining a telehealth platform or starting your own practice across multiple states, understanding these scope differences is critical.

For Psychiatrists: You can obtain licenses in multiple states (Interstate Medical Licensure Compact helps if states are members—Texas, Pennsylvania, and Illinois are in the IMLC; New York, Florida, and California are not) and practice with the same authority in each. Your biggest concern is ensuring you meet each state’s telehealth regulations (consent requirements, emergency protocols, etc.) and check that state’s prescription monitoring program.

For PMHNPs: You need to verify scope-of-practice rules in every state where you see patients. An NP licensed in New York with 5 years of experience has full authority in New York. If that same NP gets a Texas license via the APRN Compact, they’re still subject to Texas’s supervision requirements when seeing Texas patients—meaning they’d need a Texas physician collaborator. The APRN Compact (which Texas joined in 2023) streamlines licensure but does not override state scope laws.

This is why many telehealth companies structure their provider networks differently by state—psychiatrist-heavy in restricted states like Texas and Florida, more NP-driven in full-practice states like Colorado and Washington.

What Collaborative Agreements Actually Require

If you’re a PMHNP in a reduced or restricted practice state, or a psychiatrist being asked to collaborate with NPs, here’s what these agreements typically involve:

The Basics

A collaborative practice agreement (CPA) is a formal written document between an NP and a physician that outlines:

• Scope of practice: What conditions the NP can diagnose and treat
• Prescriptive authority: What medications the NP can prescribe, including formulary limits
• Supervision structure: How often the physician and NP must meet or communicate
• Chart review requirements: What percentage of cases the physician must review and how often
• Emergency protocols: What happens if the NP encounters a clinical situation beyond their scope

State-Specific Requirements

Texas:

• Must include a plan for prescriptive authority if NP will prescribe
• Requires monthly face-to-face meetings between NP and physician for first 3 years, then quarterly
• Physician can supervise maximum 7 NPs/PAs at once
• Agreement must be updated if practice site changes
• Schedule II prescribing generally not permitted for NPs in outpatient psychiatry

Florida:

• For psychiatric NPs to prescribe psychotropic controlled substances, the collaborating physician must be a psychiatrist
• Protocol must specify which medications NP can prescribe
• NP must have at least 2 years of experience under a psychiatrist to be designated a ‘psychiatric nurse’ with expanded prescribing
• No specific meeting frequency mandated by statute, but protocol must ensure physician availability

Pennsylvania:

• Collaborative agreement must be filed with State Board of Nursing
• Physician must review charts regularly (often interpreted as 10% of charts or a set number monthly)
• Schedule II prescriptions limited to 30-day supply; physician must be notified within 24 hours of prescribing
• Physician and NP must meet face-to-face at least twice per year to review agreement
• Formulary must be specified in agreement (what drugs NP can/cannot prescribe)

Illinois (for NPs without FPA):

• Written collaborative agreement required detailing scope and prescriptive authority
• Physician’s name must appear on NP’s prescriptions as delegating authority
• No specific chart review percentage mandated, but physician must be available for consultation
• After 4,000 hours + 250 CE hours, NP can apply for FPA and drop the agreement

New York (first 3,600 hours):

• Written practice agreement and protocols required initially
• No mandatory meeting frequency or chart review percentage in state law
• Agreement is more of a mentorship framework than strict supervision
• After 3,600 hours, NP files attestation and practices independently (though must maintain ‘collaborative relationships’ for consultation)

The Hidden Costs

Collaborative agreements aren’t just administrative paperwork—they have real financial and operational implications:

For NPs:

• Many physicians charge fees to serve as collaborators, ranging from $1,000-3,000/month depending on the state and level of involvement required
• Finding a collaborating psychiatrist in rural or underserved areas can be nearly impossible (why many NPs migrate to FPA states)
• Practice autonomy is limited—you can only prescribe what your collaborator approves, which may be more restrictive than state law allows

For Psychiatrists:

• Chart review takes time (even 10% of an NP seeing 100 patients/month is 10 charts to review)
• Liability concerns—you’re taking on some level of oversight responsibility
• State caps on how many NPs you can supervise limit scalability
• Administrative burden of maintaining agreements, updating protocols, and staying compliant with changing regulations

For telehealth platforms:

• Must hire or contract psychiatrists to oversee NPs in restricted states
• Compliance complexity increases with multi-state operations
• Revenue per visit may be lower if NPs bill at 85% of physician rates, but psychiatrist overhead is higher

Despite these challenges, collaborative models can work well—many telehealth platforms have medical directors who oversee NPs efficiently, and the expanded patient access often outweighs the administrative burden. But it’s critical to understand what’s legally required versus what’s operationally practical.

Telehealth-Specific Prescribing Rules by State

Federal law sets the baseline, but states add their own layers. Here’s what you need to know about prescribing via telehealth in the major psychiatric markets:

Federal Baseline (DEA Rules)

Current status (through Dec 31, 2025):

• Providers can prescribe controlled substances via telemedicine without an initial in-person exam
• Standard of care still applies (thorough evaluation required)
• Applies to all psychiatric medications including Schedule II stimulants, benzodiazepines, and buprenorphine

Pending changes:The DEA has proposed new rules that may require:

• Special telemedicine DEA registration
• In-person exam requirement after initial 30-day teleprescription
• Exceptions if another provider did an in-person exam within 12 months, or for ‘special registration’ telemedicine practices

These rules have been proposed but not finalized. The DEA has extended the temporary flexibilities multiple times, most recently through the end of 2025. Providers should monitor federal register announcements for final rules, but as of February 2026, the flexibilities remain in place.

California

Telehealth prescribing: Allowed for all psychiatric medications if a ‘good faith exam’ is conducted. Telehealth exams via video meet this standard—no in-person requirement.

Controlled substances: Follow federal DEA rules. During the current waiver period, psychiatrists and PMHNPs can prescribe Schedule II-V medications via telemedicine.

CURES (CA’s PMP): Required check before prescribing Schedule II-IV drugs. Must re-check at least once every 4 months for ongoing controlled substance therapy.

Reimbursement: AB 744 (2019) requires private payers to reimburse telehealth at parity with in-person for contracts issued after 2021. Medicare and Medicaid also pay equally.

NP prescribing via telehealth: Depends on NP’s certification status. Experienced NPs (103 or 104 status) can prescribe controlled substances independently via telehealth. New NPs must operate under standardized procedures with physician oversight.

Texas

Telehealth prescribing: Allowed if standard of care is met via real-time audio-visual interaction.

Controlled substances: Texas prohibits prescribing Schedule II opioids for chronic pain via telemedicine (must see in person). However, mental health treatment is exempt—psychiatrists can prescribe stimulants or other controlled substances for ADHD, anxiety, etc., via telehealth as long as federal law allows it.

NP restrictions: PMHNPs generally cannot prescribe Schedule II controlled substances in outpatient settings via telemedicine or otherwise (except very narrow exceptions for terminal illness or specific pediatric ADHD protocols). Schedule III-V allowed with physician delegation.

PMP: Texas requires checking the PMP (Prescription Drug Monitoring Program) before prescribing any controlled substance.

Reimbursement: Texas has telehealth coverage laws but does not mandate payment parity. Many private insurers voluntarily pay equal rates for tele-mental health due to high demand.

Key compliance point: Ensure you document the visit was via telemedicine, patient location, and that you have an emergency plan if patient is in crisis and disconnects.

Florida

Telehealth prescribing: Florida is one of the most permissive states for psychiatric teleprescribing. State law explicitly allows prescribing controlled substances via telehealth for the treatment of psychiatric disorders (this exception doesn’t apply to chronic pain management).

Controlled substances: Psychiatrists can prescribe Schedule II-V medications for mental health conditions via telemedicine. PMHNPs designated as ‘psychiatric nurses’ can also prescribe psychotropic controlled substances for mental illness in collaboration with a psychiatrist, without the 7-day Schedule II limit that applies to other NPs.

Out-of-state providers: Florida allows out-of-state physicians to register for telehealth (special registration), but this registration does not permit prescribing controlled substances—you need full Florida licensure for that.

NP scope: PMHNPs are excluded from Florida’s autonomous practice law. They must practice under a physician’s protocol and have a psychiatrist collaborator to prescribe psychotropic controlled substances.

Reimbursement: No state-mandated parity, but most insurers cover tele-mental health at equal rates. Medicare and Medicaid follow federal parity rules.

New York

Telehealth prescribing: Fully supported. New York updated its regulations in 2023-2025 to align state controlled substance prescribing rules with federal DEA flexibilities.

Controlled substances: Psychiatrists and experienced PMHNPs (post-3,600 hours) can prescribe controlled substances via telemedicine under the current federal waiver. New York’s rule creates exceptions to the in-person requirement that mirror federal allowances—so as long as the DEA waiver is in effect, you can prescribe.

PMP (I-STOP): Must check New York’s prescription monitoring registry before prescribing any Schedule II-IV drug. E-prescribing is mandatory for all controlled substances (no paper scripts).

NP scope: After 3,600 hours, PMHNPs practice independently and can prescribe controlled substances via telehealth just like psychiatrists. Before 3,600 hours, they need a collaborative agreement but can still prescribe under physician delegation.

Medicare requirement: For Medicare patients receiving tele-mental health services, there’s a requirement for at least one in-person visit every 6-12 months (federal Medicare rule, not NY-specific state law). This primarily affects billing compliance rather than legal prescribing authority.

Reimbursement: New York requires all insurers to cover telehealth. Payment parity is mandated for behavioral health services.

Pennsylvania

Telehealth prescribing: Allowed for psychiatric care. Pennsylvania defers to federal law on controlled substance prescribing via telemedicine, so current DEA waivers apply.

Controlled substances: Psychiatrists can prescribe Schedule II-V via telehealth under federal allowances. PMHNPs can prescribe Schedule III-V with physician delegation; Schedule II prescriptions limited to 30-day supply and require physician notification within 24 hours.

NP scope: All PMHNPs must maintain collaborative agreements indefinitely (no FPA pathway yet). For telehealth, this means the collaborating physician must be part of the practice structure.

Reimbursement: Pennsylvania Medicaid and many private payers cover telehealth at parity. State expanded telehealth coverage permanently post-pandemic, though comprehensive parity legislation is still evolving.

Illinois

Telehealth prescribing: Fully supported with strong parity laws. SB 667 (2021) mandates private insurers reimburse telehealth at equal rates through at least 2027.

Controlled substances: Psychiatrists can prescribe all controlled substances via telehealth under federal waivers. PMHNPs with Full Practice Authority can prescribe Schedule II-V independently; those without FPA can prescribe Schedule III-V with delegation, and Schedule II for 30 days in consultation with physician.

NP scope: Transition-to-independence model. After 4,000 hours + 250 CE hours, PMHNPs get full prescriptive authority including controlled substances. Until then, they operate under physician delegation.

Special note: Illinois allows licensed clinical psychologists with specialized training to prescribe a limited formulary of mental health medications under psychiatrist supervision—unique among states and aimed at addressing psychiatrist shortages.

Reimbursement: Excellent telehealth parity for behavioral health. Both Medicaid and private insurance pay equal rates.

Key Takeaway

If you’re practicing telepsychiatry, the golden rules are:

1. Be licensed in the state where the patient is located at the time of the visit
2. Follow that state’s scope-of-practice and prescribing rules (NPs especially need to verify their authority in each state)
3. Check the prescription monitoring program in that state before prescribing controlled substances
4. Document thoroughly – note it’s a telehealth visit, patient location, that you verified identity, and that you have an emergency plan
5. Stay current on DEA policy – the federal waivers could change, affecting your ability to prescribe controlled substances remotely

Most importantly: the telehealth prescribing landscape favors psychiatry. Mental health is one of the few specialties where insurers, states, and federal regulators have actively expanded access and maintained payment parity. Use that to your advantage.

Medication Management Reimbursement: What You’ll Actually Get Paid

Understanding reimbursement is critical for practice sustainability. Here’s what psychiatrists and PMHNPs can expect to earn for medication management visits in 2026:

Common Billing Codes

Initial Evaluation:

• CPT 90792 (Psychiatric Diagnostic Evaluation with Medical Services) – 60-minute initial consult
• Medicare 2026 rate: ~$173 national average
• Private insurance: typically $200-300 depending on region and payer

Follow-up Medication Management:

• 99213 (15-20 min, straightforward) – Most common code for routine med checks
• Medicare 2026: $92-96
• Private insurance: $120-180
• 99214 (25-30 min, moderate complexity)
• Medicare 2026: $125-136
• Private insurance: $150-220
• 99215 (40+ min, high complexity) – Rarely used for routine med management
• Medicare 2026: ~$192
• Private insurance: $220-300

Combined Medication Management + Psychotherapy:If you do therapy in the same visit, add psychotherapy codes:

• 90833 (30 min psychotherapy add-on) – adds ~$80 to the E/M code
• 90836 (45 min psychotherapy add-on) – adds ~$110
• 90838 (60 min psychotherapy add-on) – adds ~$135

Medicare vs Private Insurance vs Medicaid

Medicare:

• Reimburses telehealth mental health services at the same rate as in-person (telehealth parity is permanent for behavioral health)
• NPs are paid at 85% of physician fee schedule when billing under their own NPI
• Audio-only mental health visits are covered through 2024-2025 (extended flexibility for patients without video access)
• Requirement for occasional in-person visit every 6-12 months for Medicare telehealth (though implementation has been flexible)

Private Insurance:

• Rates vary widely by region and payer but generally exceed Medicare
• Many states mandate telehealth payment parity for mental health (Illinois, California, New York, Connecticut, Georgia, Massachusetts)
• Parity laws typically require coverage at same rate as in-person, but not all states mandate this
• NPs may be paid at 85-100% of physician rates depending on credentialing and contract terms

Medicaid:

• Typically pays less than Medicare per visit ($60-90 for a med check in many states)
• Most states cover telehealth for mental health at parity with in-person
• Some states have enhanced rates or case management fees for psychiatric collaborative care
• High patient volume can compensate for lower per-visit rates

Real-World Revenue Example

Psychiatrist seeing 25 patients/week for med management (mix of initial and follow-ups):

Assuming:

• 5 initial evals (90792) at $200 avg = $1,000
• 20 follow-ups (99213-214) at $150 avg = $3,000
• Weekly revenue: $4,000
• Monthly: ~$16,000
• Annual: ~$192,000 in professional fees

This is before overhead (if solo practice) or employer revenue share (if employed). Telehealth typically has lower overhead than in-person practice (no office lease, minimal staff needed).

PMHNP doing the same volume:At 85% reimbursement for Medicare/some private payers:

• Weekly: ~$3,400
• Monthly: ~$13,600
• Annual: ~$163,200

However, if the NP works in an independent practice state and bills privately or out-of-network, they can charge full rates. Many cash-pay telepsychiatry NPs charge $100-200/visit for ADHD med management, generating similar or higher revenue than insurance-based psychiatrists.

The Economics of Telehealth vs In-Person

Advantages of telehealth reimbursement:

• Payment parity means you get the same rate as in-person
• Lower no-show rates (patients don’t need to commute) improve actual revenue
• Can see patients across multiple states, expanding payer mix
• Lower overhead (no office rent, smaller staff, minimal equipment beyond computer/camera)
• Schedule flexibility allows more efficient use of time (back-to-back appointments without patient transport time)

Disadvantages:

• Some payers still have credentialing hurdles for telehealth
• Audio-only visits (while covered by Medicare) may be reimbursed at lower rates by some private payers
• Multi-state practice requires licenses in each state (and potentially separate payer contracts)
• Technology issues can disrupt sessions (though less of a concern in 2026 than early pandemic years)

Emerging Reimbursement Models

Collaborative Care Model (CoCM):Psychiatrists can bill monthly care management codes (99492, 99493, etc.) when consulting with primary care teams:

• 99492 (initial month): ~$161 from Medicare
• 99493 (subsequent months): ~$130 per patient/month
• Some states’ Medicaid programs also reimburse these codes

This is separate from direct patient visits and can be a significant revenue stream for psychiatrists working with primary care networks via telehealth.

Value-Based Care Incentives:Some insurers offer bonuses for quality metrics like:

• Effective continuation of antidepressants for 6+ months (HEDIS measure)
• Follow-up within 7 days of psychiatric hospitalization
• Medication adherence rates

While not yet widespread in fee-for-service psychiatry, this is a growing trend that could affect future reimbursement.

Key Reimbursement Takeaways

1. Telehealth pays the same as in-person for mental health in most markets (Medicare, most states with parity laws)
2. Psychiatrists earn ~15% more per visit than NPs under standard insurance reimbursement (85% rule), but NPs in cash-pay or out-of-network models can close this gap
3. Medication management is well-reimbursed compared to other specialties—a 15-minute med check at $95+ is efficient revenue generation
4. Documentation drives coding—ensure you’re capturing the appropriate level of service (time-based or complexity-based) to maximize legitimate reimbursement
5. Payer mix matters—a practice with 70% commercial insurance will generate significantly more revenue than one with 70% Medicaid, even seeing the same number of patients

For providers considering platforms like Klarity Health: understand how the platform handles billing and what percentage you receive. A platform charging patients directly and paying providers a flat fee per visit eliminates insurance hassle but may pay differently than billing insurance yourself. Evaluate the economics: if Klarity pays you $120 per 20-minute appointment and handles all patient acquisition and billing, compare that to billing insurance yourself at $150 but spending 20+ hours/month on administrative work.

Why Klarity Health Makes Economic Sense for Psychiatric Prescribers

Here’s the uncomfortable truth about building a psychiatric practice in 2026: patient acquisition is expensive, uncertain, and time-consuming.

The Real Cost of DIY Marketing

Many providers think they can save money by handling their own marketing. Here’s what that actually costs:

SEO (Search Engine Optimization):

• Takes 6-12 months of consistent investment before generating meaningful patient flow
• Requires content creation, website optimization, technical SEO, link building
• Typical cost: $1,500-3,000/month for a qualified agency, or equivalent staff time
• Most solo providers lack the expertise or patience for this—you’re competing against established practices and large health systems with dedicated marketing teams

Google Ads:

• Mental health keywords cost $15-40+ per click
• Most clicks don’t convert to booked patients (average conversion rate 2-5%)
• Realistic cost per booked patient through PPC: $200-400+
• Requires ongoing optimization and budget for failed campaigns

Directory Listings (Psychology Today, Zocdoc, etc.):

• Monthly subscription fees: $30-100+ per directory
• Zocdoc charges per booking ($35-100+ per lead)
• You compete with hundreds of other providers on the same page
• Low booking rates mean you’re paying for visibility, not guaranteed patients

The Bottom Line:When you factor in ALL costs—agency fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, months of SEO investment before results, and failed campaigns—acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient.

And here’s the kicker: you pay all of this upfront with no guarantee of results. That’s $3,000-5,000/month in marketing spend before you see your first patient from those channels.

How Klarity Health Changes the Economics

Klarity uses a pay-per-appointment model (similar to Zocdoc) where providers pay a standard listing fee per new patient lead. But unlike DIY marketing, you only pay when a qualified patient actually books with you.

The Value Proposition:

No upfront marketing spend or monthly subscriptions

• You’re not gambling $3,000-5,000/month on marketing channels that may or may not work
• No agency retainers, no ad budget to optimize, no directory fees piling up

Pre-qualified patients matched to your specialty and availability

• Patients come to Klarity seeking psychiatric care—they’re not cold leads who clicked an ad
• You’re matched with patients who fit your specialties (ADHD, depression, anxiety, etc.)
• Scheduling is handled, reducing staff time and administrative burden

No wasted ad spend on clicks that don’t convert

• Unlike Google Ads where you pay $30 per click and maybe 3% book, you only pay when a patient actually completes an appointment
• That’s guaranteed ROI vs gambling on marketing channels

Built-in telehealth infrastructure

• No separate platform costs (EMR, telehealth video, scheduling, billing support)
• HIPAA-compliant infrastructure maintained and updated for you
• No IT headaches or technology troubleshooting

Both insurance and cash-pay patient flow

• Diversified revenue streams—some patients use insurance, others pay cash
• Klarity handles verification and billing coordination
• You focus on clinical care, not chasing claims

You control your schedule—only pay when you see patients

• Set your own availability and appointment types
• Scale up or down based on your capacity
• No obligation to hit patient volume targets to justify marketing spend

The Math

Let’s compare:

DIY Marketing Scenario:

• Monthly marketing spend: $4,000
• New patients acquired: 10-15 (if you’re doing it well)
• Cost per patient: $267-400
• Time spent on marketing/admin: 20+ hours/month
• Total investment before seeing revenue: $4,000 + 20 hours + uncertain results

Klarity Health Scenario:

• Monthly platform fee: $0 upfront
• New patients: Whatever you can accommodate in your schedule
• Cost per patient: Standard listing fee per booked appointment (similar to Zocdoc)
• Time spent on marketing/admin: 0 (Klarity handles patient acquisition, scheduling, billing support)
• Total investment: Only pay when you see patients, zero marketing time

The ROI Difference:

If a 30-minute medication management visit generates $150 in revenue, and your patient acquisition cost is $250 (DIY marketing), you’re only netting $150 – $250 = -$100 on the first visit. You’re gambling that the patient will stay long enough (multiple follow-ups) to break even.

With Klarity’s

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship